Osenvelt 120 mg/1.7mL
denosumab-bmwo · INJECTION · CELLTRION USA, Inc.
No Recall History
Plain English
Osenvelt is a injection containing denosumab-bmwo at 120 mg/1.7mL, taken subcutaneous. Manufactured by CELLTRION USA, Inc..
Key Facts
- Brand Name
- Osenvelt
- Generic Name
- denosumab-bmwo
- NDC Code (Product)
72606-038- Manufacturer
- CELLTRION USA, Inc.
- Strength
- 120 mg/1.7mL
- Dosage Form
- INJECTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761404
- Drug Class
- RANK Ligand Inhibitor [EPC]
- Marketing Start
- 07/02/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is Osenvelt used for?
Osenvelt contains denosumab-bmwo. It is a injection taken subcutaneous. Consult your doctor for specific uses.
Is Osenvelt a controlled substance?
Osenvelt is not classified as a controlled substance by the DEA.
What is the generic name for Osenvelt?
The generic name for Osenvelt is denosumab-bmwo. There are 3 other brand versions of denosumab-bmwo.
What is the NDC code for Osenvelt 120 mg/1.7mL?
The NDC (National Drug Code) for Osenvelt 120 mg/1.7mL is 72606-038, listed by CELLTRION USA, Inc..